5th Annual
Marie Skłodowska-Curie
Symposium on Cancer Research
and Care
September 3-5, 2025
Warsaw, Poland
Our mission
Better future for oncology
The symposium aims to promote collaboration among scientists, clinicians, and representatives from the biotechnology and pharmaceutical sectors from the USA, Canada, and Central and Eastern European countries. The event seeks to accelerate the development and testing of new cancer therapies and improve care for oncology patients.
History of the Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care
The Annual Marie Skłodowska-Curie Symposium on Cancer Research and Care was initiated in May 2019 during the 60 Million Congress/Global Polonia Summit in Buffalo. The event aimed to unite scientists, educators, and oncology care specialists from the USA and Poland. After a hiatus due to the COVID-19 pandemic, the second edition took place in September 2022 in a hybrid format, gathering 112 participants from various countries, including Poland, Ukraine, Hungary, the Czech Republic, Croatia, Canada, and the USA. The third edition was held in September 2023 at the Roswell Park Comprehensive Cancer Center in Buffalo, attracting 137 participants from 20 academic institutions and representatives from the biotech and pharmaceutical sectors.
Significance of the Event for International Collaboration
The symposium plays a crucial role in promoting international collaboration among scientists, clinicians, and representatives from the biotechnology and pharmaceutical sectors from the USA, Canada, and Central and Eastern European countries. This collaboration accelerates the development and testing of new cancer therapies and improves care for oncology patients. The event fosters the exchange of knowledge, experiences, and the establishment of lasting scientific and clinical partnerships.
The symposium covers a wide range of topics
related to oncology, including:
- Basic and translational cancer research.
- New therapeutic strategies and innovative treatment methods.
- Early detection and prevention of cancers.
- Biomarker research and clinical applications.
- Challenges and solutions in patient care.
- Health policy and its impact on cancer prevention and treatment.
- Education and training in oncology.
Information about the Model:
Year A in Europe, Year B in the USA
Starting from 2025, the symposium adopts a rotational model: in odd-numbered years (Year A), it takes place in Europe, and in even-numbered years (Year B), in the USA. The first European edition will be held in Warsaw from September 3-5, 2025, highlighting Poland’s significance in the international oncology community. The subsequent edition is planned for 2026 in Tampa, Florida.
Who Should Attend?
This symposium is intended for:
- Scientists and researchers in oncology and biotechnology,
- Physicians and healthcare specialists,
- Representatives of the pharmaceutical and biotech industries,
- Policymakers and health organization representatives,
- Students and young scientists interested in oncology.
Call for Abstracts
We warmly invite you to actively participate in the symposium and to submit abstracts highlighting research projects born through international collaboration.
Join us in advancing innovative cancer therapies, early detection strategies, and improved patient care across borders!
Partners
Partner with us in shaping the future of cancer research and care. The MSCS-CRC Symposium offers a unique platform to connect with top oncology professionals, increase your brand’s visibility, and demonstrate your commitment to advancing global health.